share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  09/10 17:04

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 09/10/2024, with an aggregate market value of $92,498.87. The shares were originally acquired on 07/18/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned sale follows a series of transactions over the past three months where a total of 90,000 shares were sold for gross proceeds of $687,667.20.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 09/10/2024, with an aggregate market value of $92,498.87. The shares were originally acquired on 07/18/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned sale follows a series of transactions over the past three months where a total of 90,000 shares were sold for gross proceeds of $687,667.20.
Recursion Pharmaceuticals, Inc.的高管Secora Michael計劃於2024年09/10賣出15,000股A類股份,總市值爲92,498.87美元。這些股份最初是在2023年07/18通過股票期權行權從發行方獲得的,當日以現金支付。這次計劃的出售是在過去三個月中進行一系列交易的結果,共售出90,000股,總交易額爲687,667.20美元。
Recursion Pharmaceuticals, Inc.的高管Secora Michael計劃於2024年09/10賣出15,000股A類股份,總市值爲92,498.87美元。這些股份最初是在2023年07/18通過股票期權行權從發行方獲得的,當日以現金支付。這次計劃的出售是在過去三個月中進行一系列交易的結果,共售出90,000股,總交易額爲687,667.20美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息